Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial

OBJECTIVE: To evaluate whether 1% aqueous chlorhexidine gluconate (CHG) when compared with 2% aqueous chlorhexidine gluconate is non-inferior for neonatal skin antisepsis. DESIGN: Parallel, blinded, non-inferiority randomised trial. SETTING: Level III, academic, neonatal intensive care unit. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Akash, Kulkarni, Srikant, Thukral, Anu, Sankar, M Jeeva, Agarwal, Ramesh, Deorari, A K, Mohapatra, Sarita, Velpandian, Thirumurthy, Bajpai, Minu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543223/
https://www.ncbi.nlm.nih.gov/pubmed/34108192
http://dx.doi.org/10.1136/archdischild-2020-321174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543223/
https://www.ncbi.nlm.nih.gov/pubmed/34108192
http://dx.doi.org/10.1136/archdischild-2020-321174

Ejemplares similares